Methylnaltrexone - PowerPoint PPT Presentation
Title:
Methylnaltrexone
Description:
Methylnaltrexone GMK Malignant Melanoma- discontinued HIV Entry Inhibitors PRO 542 PII(single dose) (n=12) - 60-80% reduction in viral load PII(multi-dose) - ongoing ... – PowerPoint PPT presentation
Number of Views:96
Avg rating:3.0/5.0
Title: Methylnaltrexone
1
(No Transcript)
2
(No Transcript)
3
Methylnaltrexone
4
GMK Malignant Melanoma- discontinued
Cancer Vaccines
PSMA - Joint Venture with Cytogen Phase 1
prostate cancer vaccine Preclin - antibody and
viral vector
5
HIV Entry Inhibitors
- PRO 542
- PII(single dose) (n12) - 60-80 reduction in
viral load - PII(multi-dose) - ongoing
- Preclinical PRO 140, Provax
6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
Cash ? Burn Rate Quarters Left (22.5 - 2.6) ?
7.4 2.6
Expect Upcoming Financing!
